Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1341)
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
48,211
Price
$2.42
Total Value
$116.67K
Shares Held After
2,790,103
% of Holdings
1.7%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
300
Price
$85.63
Total Value
$25.69K
Shares Held After
15,312
% of Holdings
1.9%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
5,656
Price
$84.90
Total Value
$480.20K
Shares Held After
15,612
% of Holdings
26.6%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
3,743
Price
$84.26
Total Value
$315.37K
Shares Held After
21,268
% of Holdings
15.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
300
Price
$83.07
Total Value
$24.92K
Shares Held After
25,011
% of Holdings
1.2%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
43,367
Price
$2.43
Total Value
$105.38K
Shares Held After
2,741,892
% of Holdings
1.6%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
268
Price
$29.40
Total Value
$7.88K
Shares Held After
822,240
% of Holdings
0.0%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
19,799
Price
$28.61
Total Value
$566.41K
Shares Held After
822,508
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$553.47
Total Value
$44.28K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$548.44
Total Value
$219.38K
Shares Held After
40,593
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,578
Price
$547.17
Total Value
$863.44K
Shares Held After
40,993
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,438
Price
$546.42
Total Value
$785.75K
Shares Held After
42,571
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,524
Price
$545.54
Total Value
$831.41K
Shares Held After
44,009
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
364
Price
$544.54
Total Value
$198.21K
Shares Held After
45,533
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
676
Price
$543.34
Total Value
$367.30K
Shares Held After
45,897
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,870
Price
$542.49
Total Value
$1.01M
Shares Held After
46,573
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
970
Price
$541.47
Total Value
$525.23K
Shares Held After
48,443
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$540.37
Total Value
$324.22K
Shares Held After
49,413
% of Holdings
1.2%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
15,000
Price
$17.61
Total Value
$264.12K
Shares Held After
179,090
% of Holdings
7.7%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
1,700
Price
$2.70
Total Value
$4.59K
Shares Held After
385,075
% of Holdings
0.4%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$3.04
Total Value
$15.20K
Shares Held After
635,812
% of Holdings
0.8%
Taysha Gene Therapies, Inc. (TSHA)
Nagendran Sukumar — Director
Shares
200,000
Price
$6.24
Total Value
$1.25M
Shares Held After
936,410
% of Holdings
17.6%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,000
Price
$0.94
Total Value
$940.00
Shares Held After
369,485
% of Holdings
0.3%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
229
Price
$73.95
Total Value
$16.93K
Shares Held After
492,241
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
325
Price
$550.59
Total Value
$178.94K
Shares Held After
450
% of Holdings
41.9%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
7
Price
$2.48
Total Value
$17.36
Shares Held After
2,698,525
% of Holdings
0.0%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
48,502
Price
$30.05
Total Value
$1.46M
Shares Held After
842,307
% of Holdings
5.4%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
2,464
Price
$90.25
Total Value
$222.38K
Shares Held After
60,299
% of Holdings
3.9%
PTC THERAPEUTICS, INC. (PTCT)
Smith Mary L. — Director
Shares
5,834
Price
$90.00
Total Value
$525.06K
Shares Held After
21,813
% of Holdings
21.1%
PTC THERAPEUTICS, INC. (PTCT)
Smith Mary L. — Director
Shares
10,000
Price
$90.00
Total Value
$900.00K
Shares Held After
21,813
% of Holdings
31.4%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
112,422
Price
$90.00
Total Value
$10.12M
Shares Held After
8,383
% of Holdings
93.1%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
36,167
Price
$84.00
Total Value
$3.04M
Shares Held After
120,805
% of Holdings
23.0%
BridgeBio Pharma, Inc. (BBIO)
Ellis Andrea — Director
Shares
17,167
Price
$84.00
Total Value
$1.44M
Shares Held After
22,579
% of Holdings
43.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
5,566
Price
$101.97
Total Value
$567.57K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
15,329
Price
$101.24
Total Value
$1.55M
Shares Held After
5,566
% of Holdings
73.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
10,354
Price
$100.22
Total Value
$1.04M
Shares Held After
20,895
% of Holdings
33.1%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
1,875
Price
$2.50
Total Value
$4.69K
Shares Held After
29,375
% of Holdings
6.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
15,000
Price
$18.32
Total Value
$274.75K
Shares Held After
194,090
% of Holdings
7.2%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
10,053
Price
$2.79
Total Value
$28.05K
Shares Held After
383,375
% of Holdings
2.6%
ProQR Therapeutics N.V. (PRQR)
de Boer Daniel Anton — Director
Shares
150,000
Price
$1.74
Total Value
$261.00K
Shares Held After
300,000
% of Holdings
50.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,171
Price
$30.30
Total Value
$65.78K
Shares Held After
57,733
% of Holdings
3.6%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
25,000
Price
$1.96
Total Value
$48.90K
Shares Held After
461,904
% of Holdings
5.4%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,000
Price
$0.90
Total Value
$900.00
Shares Held After
368,485
% of Holdings
0.3%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
25
Price
$16.00
Total Value
$400.00
Shares Held After
135,202
% of Holdings
0.0%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
536
Price
$29.00
Total Value
$15.54K
Shares Held After
181,641
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
2,111
Price
$123.81
Total Value
$261.36K
Shares Held After
63,493
% of Holdings
3.2%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,359
Price
$118.52
Total Value
$398.11K
Shares Held After
259,058
% of Holdings
1.3%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,335
Price
$117.62
Total Value
$274.64K
Shares Held After
262,417
% of Holdings
0.9%
INSMED Inc (INSM)
Lewis William — Director
Shares
5,005
Price
$116.55
Total Value
$583.33K
Shares Held After
264,752
% of Holdings
1.9%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
10,000
Price
$40.00
Total Value
$400.00K
Shares Held After
119,763
% of Holdings
7.7%
Showing 1–50 of 1341 transactions (page 1 of 27)